Literature DB >> 27614804

Effects of Diabetes Mellitus on Cognitive Decline in Patients with Alzheimer Disease: A Systematic Review.

Jun Li1, Matteo Cesari2, Fei Liu3, Birong Dong4, Bruno Vellas2.   

Abstract

Basic and clinical research support a link between diabetes mellitus and Alzheimer disease (AD). However, the relationship with AD progression is unclear. This review focuses on the association between diabetes and cognitive decline in patients with AD. The literature published through May 2015 was searched in 3 databases: PubMed, Embase and Cochrane. Studies evaluating the effects of diabetes on patients with AD or cognitive decline were included, and extracted data were analyzed. A total of 10 articles met the inclusion criteria for review. The results of these studies were inconsistent in terms of the association between diabetes and cognitive decline. Only 2 studies demonstrated that the presence of diabetes was independently related to the progression of cognitive decline in the patients with AD, and 3 studies suggested that histories of diabetes were not correlated with the changes in cognitive function in patients with AD. Half of the included studies even indicated that histories of diabetes were associated with lesser declines in cognitive function in patients with AD. Current evidence indicates that the link between diabetes and cognitive decline in patients with AD is uncertain. Further clinical studies are needed, with larger samples, long-term follow up and an extended battery of cognitive assessments.
Copyright © 2016 Canadian Diabetes Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer disease; cognitive decline; cognitive function; diabetes mellitus; diabète sucré; déclin cognitif; examen systématique; fonctionnement cognitif; maladie d'Alzheimer; systematic review

Mesh:

Year:  2016        PMID: 27614804     DOI: 10.1016/j.jcjd.2016.07.003

Source DB:  PubMed          Journal:  Can J Diabetes        ISSN: 1499-2671            Impact factor:   4.190


  24 in total

1.  Longitudinal Cognitive Profiles in Diabetes: Results From the National Alzheimer's Coordinating Center's Uniform Data.

Authors:  Mary Sano; Carolyn W Zhu; Hillel Grossman; Corbett Schimming
Journal:  J Am Geriatr Soc       Date:  2017-08-03       Impact factor: 5.562

2.  Glycosylated hemoglobin level, race/ethnicity, and cognition in midlife and early old age.

Authors:  Kasim Ortiz; Marc A Garcia; Emily Briceño; Erica D Diminich; Sandra P Arévalo; Irving E Vega; Wassim Tarraf
Journal:  Res Hum Dev       Date:  2020-07-01

Review 3.  Metformin - a Future Therapy for Neurodegenerative Diseases : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla.

Authors:  Magdalena Markowicz-Piasecka; Joanna Sikora; Aleksandra Szydłowska; Agata Skupień; Elżbieta Mikiciuk-Olasik; Kristiina M Huttunen
Journal:  Pharm Res       Date:  2017-06-06       Impact factor: 4.200

4.  Association between vascular comorbidity and progression of Alzheimer's disease: a two-year observational study in Norwegian memory clinics.

Authors:  Rannveig Sakshaug Eldholm; Karin Persson; Maria Lage Barca; Anne-Brita Knapskog; Lena Cavallin; Knut Engedal; Geir Selbaek; Eva Skovlund; Ingvild Saltvedt
Journal:  BMC Geriatr       Date:  2018-05-22       Impact factor: 3.921

5.  A Comparative Assessment of Biological Effects and Chemical Profile of Italian Asphodeline lutea Extracts.

Authors:  Dora Melucci; Marcello Locatelli; Clinio Locatelli; Alessandro Zappi; Francesco De Laurentiis; Simone Carradori; Cristina Campestre; Lidia Leporini; Gokhan Zengin; Carene Marie Nancy Picot; Luigi Menghini; Mohamad Fawzi Mahomoodally
Journal:  Molecules       Date:  2018-02-19       Impact factor: 4.411

Review 6.  Alzheimer's Disease, Oligomers, and Inflammation.

Authors:  Gianluigi Forloni; Claudia Balducci
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

7.  Differential effects of risk factors on the cognitive trajectory of early- and late-onset Alzheimer's disease.

Authors:  Jaeho Kim; Sook-Young Woo; Seonwoo Kim; Hyemin Jang; Junpyo Kim; Jisun Kim; Sung Hoon Kang; Duk L Na; Juhee Chin; Liana G Apostolova; Sang Won Seo; Hee Jin Kim
Journal:  Alzheimers Res Ther       Date:  2021-06-14       Impact factor: 6.982

8.  Bushen Huoxue Attenuates Diabetes-Induced Cognitive Impairment by Improvement of Cerebral Microcirculation: Involvement of RhoA/ROCK/moesin and Src Signaling Pathways.

Authors:  Yuan Li; Quan Li; Chun-Shui Pan; Li Yan; Bai-He Hu; Yu-Ying Liu; Lei Yang; Ping Huang; Shao-Yang Zhao; Chuan-She Wang; Jing-Yu Fan; Xue-Mei Wang; Jing-Yan Han
Journal:  Front Physiol       Date:  2018-05-15       Impact factor: 4.566

9.  Correlation between Diabetes Mellitus and Knee Osteoarthritis: A Dry-To-Wet Lab Approach.

Authors:  Navneet Kumar Dubey; Dina Nur Anggraini Ningrum; Rajni Dubey; Yue-Hua Deng; Yu-Chuan Li; Peter D Wang; Joseph R Wang; Shabbir Syed-Abdul; Win-Ping Deng
Journal:  Int J Mol Sci       Date:  2018-10-03       Impact factor: 5.923

10.  Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial.

Authors:  Brian Lawlor; Ricardo Segurado; Sean Kennelly; Marcel G M Olde Rikkert; Robert Howard; Florence Pasquier; Anne Börjesson-Hanson; Magda Tsolaki; Ugo Lucca; D William Molloy; Robert Coen; Matthias W Riepe; János Kálmán; Rose Anne Kenny; Fiona Cregg; Sarah O'Dwyer; Cathal Walsh; Jessica Adams; Rita Banzi; Laetitia Breuilh; Leslie Daly; Suzanne Hendrix; Paul Aisen; Siobhan Gaynor; Ali Sheikhi; Diana G Taekema; Frans R Verhey; Raffaello Nemni; Flavio Nobili; Massimo Franceschi; Giovanni Frisoni; Orazio Zanetti; Anastasia Konsta; Orologas Anastasios; Styliani Nenopoulou; Fani Tsolaki-Tagaraki; Magdolna Pakaski; Olivier Dereeper; Vincent de la Sayette; Olivier Sénéchal; Isabelle Lavenu; Agnès Devendeville; Gauthier Calais; Fiona Crawford; Michael Mullan
Journal:  PLoS Med       Date:  2018-09-24       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.